Previous close | 3,448.00 |
Open | 3,469.00 |
Bid | 3,465.00 x 0 |
Ask | 3,466.00 x 0 |
Day's range | 3,439.00 - 3,488.00 |
52-week range | 2,431.00 - 3,531.00 |
Volume | |
Avg. volume | 399,486 |
Market cap | 6.476T |
Beta (5Y monthly) | 0.46 |
PE ratio (TTM) | 3,687.23 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.59 (1.71%) |
Ex-dividend date | 02 May 2024 |
1y target est | N/A |
LexisNexis® Risk Solutions, a leading provider of data and analytics, today released its latest healthcare data brief highlighting new insights on key mental health trends including the continued increase in claims for mental health care, shifts in telehealth and in-person utilization, and specific diagnoses that have surged between 2019 and 2023.
LexisNexis® Risk Solutions earned recognition as a Category Leader in both the Transaction Screening and Adverse Media quadrants of the Watchlist and Adverse Media Monitoring Solutions, 2024: Market Update and Vendor Landscape report from Chartis Research.
LexisNexis® Risk Solutions, a leading provider of data and analytics, today announced that its LexisNexis® Health Equity and Inclusion Insights has been selected as the winner of the "Best Healthcare Big Data Solution" award in the 8th annual MedTech Breakthrough Awards, an independent market intelligence awards programs that recognizes the top companies, technologies and products in the global digital health and medical technology market.